{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:54:52Z","timestamp":1789260892847,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Perioperative Care and Operating Room Management"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pcorm.2021.100199","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:58:58Z","timestamp":1626440338000},"page":"100199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Routine use of sugammadex does not shorten Pacu length of stay: A prospective double-blinded randomized controlled trial"],"prefix":"10.1016","volume":"24","author":[{"given":"Germ\u00e1n","family":"Echeverry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Polskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Tollinche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Seier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay See","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pcorm.2021.100199_bib0001","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1185\/03007990902769054","article-title":"Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries","volume":"25","author":"Zhang","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.pcorm.2021.100199_bib0002","first-page":"97","article-title":"Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period","volume":"72","author":"Murphy","year":"2006","journal-title":"Minerva Anestesiol"},{"issue":"6","key":"10.1016\/j.pcorm.2021.100199_bib0003","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/ALN.0000000000000674","article-title":"Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications","volume":"122","author":"McLean","year":"2015","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.pcorm.2021.100199_bib0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2044.2006.04862.x","article-title":"Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium","volume":"62","author":"Maybauer","year":"2007","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.pcorm.2021.100199_bib0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/bja\/aeq157","article-title":"Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge","volume":"105","author":"Butterly","year":"2010","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.pcorm.2021.100199_bib0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1213\/ANE.0000000000000757","article-title":"The RECITE Study: a Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade","volume":"121","author":"Fortier","year":"2015","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.pcorm.2021.100199_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.200512-1862OC","article-title":"The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade","volume":"175","author":"Eikermann","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.pcorm.2021.100199_bib0008","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/bja\/aev104","article-title":"Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study","volume":"115","author":"Brueckmann","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pcorm.2021.100199_bib0009","doi-asserted-by":"crossref","first-page":"e6329","DOI":"10.1136\/bmj.e6329","article-title":"Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study","volume":"345","author":"Grosse-Sundrup","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.pcorm.2021.100199_bib0010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/ALN.0000000000000440","article-title":"Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study","volume":"121","author":"Sasaki","year":"2014","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.pcorm.2021.100199_bib0011","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/ALN.0b013e3181f70f3d","article-title":"Neostigmine\/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure","volume":"113","author":"Herbstreit","year":"2010","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.pcorm.2021.100199_bib0012","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.anes.0000281928.88997.95","article-title":"Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function","volume":"107","author":"Eikermann","year":"2007","journal-title":"Anesthesiology"},{"issue":"Suppl 1","key":"10.1016\/j.pcorm.2021.100199_bib0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2044.2008.05867.x","article-title":"Antagonism of non-depolarising neuromuscular block: current practice","volume":"64","author":"Kopman","year":"2009","journal-title":"Anaesthesia"},{"issue":"Suppl 1","key":"10.1016\/j.pcorm.2021.100199_bib0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2044.2008.05872.x","article-title":"Clinical implications of sugammadex","volume":"64","author":"Caldwell","year":"2009","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.pcorm.2021.100199_bib0015","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine","volume":"109","author":"Jones","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.pcorm.2021.100199_bib0016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","article-title":"Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study","volume":"104","author":"Sorgenfrei","year":"2006","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.pcorm.2021.100199_bib0017","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1213\/01.ane.0000248224.42707.48","article-title":"Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine","volume":"104","author":"Sacan","year":"2007","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.pcorm.2021.100199_bib0018","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/bja\/aen176","article-title":"Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing","volume":"101","author":"Eikermann","year":"2008","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.pcorm.2021.100199_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000542-198607000-00001","article-title":"Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans","volume":"65","author":"Donati","year":"1986","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.pcorm.2021.100199_bib0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00000542-199510000-00009","article-title":"Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block","volume":"83","author":"Brull","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pcorm.2021.100199_bib0021","article-title":"Consensus Statement on Perioperative Use of Neuromuscular Monitoring","author":"Naguib","year":"2017","journal-title":"Anesth Analg."},{"key":"10.1016\/j.pcorm.2021.100199_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEOR.S100921","article-title":"Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center","volume":"8","author":"Carron","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"10.1016\/j.pcorm.2021.100199_bib0023","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5152\/TJAR.2015.35682","article-title":"Comparison of Sugammadex versus Neostigmine Costs and Respiratory Complications in Patients with Obstructive Sleep Apnoea","volume":"43","author":"Unal","year":"2015","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"10.1016\/j.pcorm.2021.100199_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinane.2016.06.018","article-title":"Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials","volume":"35","author":"Carron","year":"2016","journal-title":"J Clin Anesth"},{"issue":"12","key":"10.1016\/j.pcorm.2021.100199_bib0025","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/anae.13277","article-title":"A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade","volume":"70","author":"Abad-Gurumeta","year":"2015","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pcorm.2021.100199_bib0026","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jclinane.2017.03.004","article-title":"Role of sugammadex in accelerating postoperative discharge: A meta-analysis","volume":"39","author":"Carron","year":"2017","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.pcorm.2021.100199_bib0027","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/CEOR.S221308","article-title":"Impact of Sugammadex Versus Neostigmine\/Glycopyrrolate on Perioperative Efficiency","volume":"12","author":"Deyhim","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.pcorm.2021.100199_bib0028","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/bja\/aew005","article-title":"Is one acceleromyographically measured train-of-four ratio sufficient after sugammadex to identify residual curarization in postoperative, awake patients?","volume":"116","author":"Unterbuchner","year":"2016","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.pcorm.2021.100199_bib0029","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","article-title":"Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): a Multicenter Matched Cohort Analysis","volume":"132","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.pcorm.2021.100199_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12871-018-0549-x","article-title":"Postoperative complications with neuromuscular blocking drugs and\/or reversal agents in obstructive sleep apnea patients: a systematic review","volume":"18","author":"Hafeez","year":"2018","journal-title":"BMC Anesthesiol"}],"container-title":["Perioperative Care and Operating Room Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405603021000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405603021000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:06:07Z","timestamp":1762502767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405603021000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S2405603021000455"],"URL":"https:\/\/doi.org\/10.1016\/j.pcorm.2021.100199","relation":{},"ISSN":["2405-6030"],"issn-type":[{"value":"2405-6030","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine use of sugammadex does not shorten Pacu length of stay: A prospective double-blinded randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Perioperative Care and Operating Room Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcorm.2021.100199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100199"}}